Durable Medical Equipment Cases Across Acquisitions: New Names, Old Claims

Durable medical equipment fraud settlements can follow allegations of free meters, forged wheelchair records or ventilator upcoding through an acquisition. A parent or successor may agree to pay while the complaint still carries an older company name. Your employer’s current name may tell only part of that story.

Why Is the Company Name Different in the Settlement?

An acquisition can put a parent or successor in a DME fraud settlement while the complaint keeps the supplier’s old name. A company rename can create the same mismatch.

The industry already uses different names for different parts of the same transaction. Medicare’s public supplier claims data identifies the billing supplier by its National Provider Identifier, not the manufacturer of the device. A product brand identifies something else again. The company on a machine, the supplier on a claim and the parent behind the supplier can therefore lead to different records.

Acquisitions also buy patient relationships and payer contracts. Equipment is only part of the business. The payment category determines whether revenue comes from a purchase, a capped rental or continuing monthly payments, while recurring supply orders bring the patient back. That gives an old order and its billing history commercial importance after a purchase.

Arriva and Alere Settled After the Supplier Closed

Arriva Medical and its parent, Alere, agreed to a $160 million settlement announced on August 2, 2021. Alere had acquired the mail-order diabetic testing supplier in November 2011. Arriva ceased operations in December 2017. The supplier had closed, but its claims remained the subject of the settlement.

The government alleged that Arriva, with Alere’s approval, offered free glucose meters and routinely waived or failed to collect copayments to induce orders. It also alleged that Arriva billed for replacement meters before patients were eligible and submitted claims for deceased beneficiaries. A former call-center employee brought the whistleblower case, which the government joined.

The government’s complaint makes the sales policy concrete. It quotes a supervisor explaining what happened when a patient did not want a meter:

The patient could say no and still get a meter for Medicare to pay for, according to the complaint. The parent’s alleged approval connects the practice to decisions above the supplier.

Abbott Laboratories had acquired Arriva and Alere in October 2017, as the government’s later reimbursement-consultant settlement announcement explains. The corporate settlement above named Arriva and Alere. Following the ownership chain and following the settlement parties give different answers.

Orbit and Rehab Medical Shared a Settlement

Orbit Medical and Rehab Medical agreed to pay $7.5 million in May 2015. The Justice Department described Rehab Medical as a partial successor of Orbit.

The government alleged that Orbit sales representatives altered prescriptions and medical records to support power-wheelchair claims. They allegedly changed dates to make prescriptions appear to have reached the supplier within 45 days of the patient’s face-to-face exam, as the rule then required. They also allegedly created or altered chart notes, forged physician signatures and added fax stamps to make documents appear to have come from a physician’s office.

Two former Orbit employees brought the whistleblower case. The companies’ settlement left claims against a former vice president and sales manager outside the agreement. For an insider at a successor business, the useful connection is specific: the predecessor’s wheelchair orders, the altered documentation and the companies named in the resolution.

QMES Became AdaptHealth, but the Complaint Kept QMES

AdaptHealth LLC, formerly QMES, agreed to a $5.3 million settlement in April 2023. The case remained under QMES, doing business as Tricounty Medical Equipment and Supply. An employee searching only the name AdaptHealth would miss the name on the complaint.

The whistleblower, a former QMES employee, alleged that the company billed Medicare for ventilators while providing BiPAP devices to patients with COPD or sleep apnea. His complaint also alleged that executives directed continued billing under incorrect codes and instructed staff not to notify payers.

The complaint describes what happened when patient charts reached a health plan. It alleges that a compliance officer asked the employee to tell the plan the charts had been sent in error and should be discarded. He said he refused and repeatedly urged the company to report the billing. The complaint describes the response:

The device supplied, the code billed, the charts sent to the payer and the instructions inside the business belong together. A new name in the settlement headline leaves that earlier paper trail worth following.

Cardinal’s Acquisition Changed the Product Name Too

Innovative Therapies and its ultimate parent, Cardinal Health, agreed to pay $2.715 million in June 2017. The Justice Department said the conduct began before Cardinal bought Innovative Therapies in August 2014. Certain Quantum wound-treatment devices became the PRO series after the purchase.

The complaint alleged that Innovative Therapies marketed those negative pressure wound-treatment devices as durable medical equipment despite knowing they lacked the expected operating life. According to the complaint, the devices came programmed with a limited number of therapy hours and were never used again once those hours expired. Suppliers allegedly billed Medicare for durable equipment on the strength of that marketing.

Quantum and PRO are the product names that connect the manufacturer’s marketing to what suppliers billed. The complaint placed the problem in the device’s preset operating hours, before a supplier entered a billing code.

A former Innovative Therapies employee brought the case. The government placed the start of the conduct before the acquisition and identified both the manufacturer and its ultimate parent in the settlement.

JAS and NEOPS Paid Separate Amounts

Joint Active Systems, a national manufacturer, and NEOPS, an orthotics and prosthetics clinic chain, settled in December 2020, with JAS paying $1.5 million and NEOPS paying $90,000. NEOPS had filed for bankruptcy in 2017 and was under new ownership when the settlement was announced.

Two former NEOPS employees brought the allegations against the clinic chain and the manufacturer. Their announced whistleblower share was 17% of the recovery. Employees inside the clinic business supplied the allegations reaching both businesses, while the settlement assigned a separate payment to each.

JAS later agreed to pay $500,000 in February 2023 to resolve allegations that it caused false claims to North Carolina Medicaid. JAS denied those allegations.

Respironics Appears Under Several Philips Names

Respironics Inc., Philips RS North America LLC and Philips Respironics appear in civil False Claims Act settlements involving alleged benefits to durable medical equipment suppliers.

In March 2016, Respironics settled allegations that it gave free call-center services to suppliers buying its sleep-apnea masks. In September 2022, the announcement named Philips RS North America, formerly Respironics, in a case involving valuable physician-prescribing data supplied to equipment providers.

The whistleblower’s complaint alleged that suppliers could use that data to identify physicians to target for sales. Respironics allegedly supplied it to encourage recommendations of its products. In that alleged arrangement, the value lay in access to future orders.

A Respironics employee brought the whistleblower case, with an announced share of approximately $4.3 million from the federal settlement amount.

A December 2023 settlement used Philips Respironics. The old name, the newer legal name and the particular arrangement connect these announcements to the business an employee knows.

Changed Ownership and the Claims That Followed

Ownership changes also appear in Medicare’s response to catheter billing. In a February 2026 notice, the Centers for Medicare & Medicaid Services described a scheme involving 15 medical equipment supply companies that had recently changed ownership. The agency said beneficiaries did not receive the catheters, physicians did not order them and the supplies were not needed. It stopped payments and revoked the suppliers’ Medicare enrollments.

That account connects an ownership change to specific findings about orders, deliveries and need. The settled cases make similarly concrete connections through product marketing, billing codes, altered charts or referral benefits. For someone working inside a health care business, the important history includes who directed those practices before and after the company’s name changed.

When Your Records Carry the Old Name

A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers. If you recognize the orders, billing instructions or product claims under an earlier company name, speak with our durable medical equipment fraud whistleblower experts. We connect that business history to the conduct you know, bring in healthcare fraud whistleblower lawyers suited to your case and stay on your side through the decisions ahead.